Software VCs Flock to Robotics Amid Biotech Funding Winter

Software VCs are aggressively pouring funds into the robotics sector despite their limited hardware knowledge. In contrast, the biotech sector remains in a funding winter despite the massive commercial success of GLP-1 drugs.

2026-08-14 ~ 2026-08-14 · 2 related posts

• Investors Hype Robotics While Biotech Suffers a Deep Funding Winter — zebird0 · 2026-08-14
• Software VCs Suddenly Excited About Robotics Hardware While Biotech Stays Frozen — zebird0 · 2026-08-14